Outcomes of rehabilitation following device-aided therapy start in parkinson's disease: a randomized controlled trial
- Journal
- Journal of rehabilitation medicine (Q1)
- Published
- 3 August 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Ann Björkdahl, Annika Khalif, Marie Gustafsson, Ann-Charlotte Lindström, Filip Bergquist
- PMID
- 42549611
- DOI
- 10.2340/jrm.v58.46068
Why clinicians should know about it
- Picked for Rehabilitation (paper of the day, 5 August 2026).
Abstract
OBJECTIVE: To determine whether adding tailored primary care rehabilitation to Device-Aided Therapy in Parkinson's disease improves outcomes more than Device-Aided Therapy alone. DESIGN: Open randomized controlled intervention trial. SUBJECTS/PATIENTS: Parkinson's patients initiating Device-Aided Therapy. METHODS: Participants were randomized to receive standard care either with or without 3 months of tailored primary care rehabilitation. The primary outcome was Assessment of Motor and Process Skills, while secondary outcomes included cognitive measures and overall treatment efficacy. RESULTS: The study was completed by 45 of 54 included patients. The primary outcome variable indicated that rehabilitation resulted in better maintenance of patient motor skills at 6 and 12 months. However, among several secondary measures, only perceived health improved more in the intervention group. Motor fluctuations improved in both groups and several other disease-specific scales demonstrated non-significant improvements. The rehabilitation group showed better cognitive performance at 12 months. CONCLUSION: Motor skills and perceived health were improved by a 3-month rehabilitation period after the start of Device-Aided Therapy for advanced Parkinson's disease. An observed positive effect of rehabilitation on cognition in the first year after the therapy requires further confirmation.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.